Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | SQLE | Q14534 | 2/20 | 0.31 |
| ▸ | LSS | P48449 | 1/20 | 0.30 |
| ▸ | FNTA | P49354 | 3/20 | 0.30 |
| ▸ | PGGT1B | P53609 | 2/20 | 0.30 |
| ▸ | FNTB | P49356 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2864562 | 1.00 | PTPN1 (0.33) | PTPN1ALDH1A1ALOX15SQLELSS | |
| SCHEMBL2867892 | 0.80 | LSS (0.38) | PTPN1ALDH1A1ALOX15LSS | |
| SCHEMBL2867890 | 0.80 | LSS (0.38) | PTPN1ALDH1A1ALOX15LSS | |
| SCHEMBL15297176 | 0.79 | FNTA (0.35) | FNTAPGGT1BFNTB | |
| SCHEMBL21067037 | 0.79 | ALDH1A1 (0.58) | PTPN1ALDH1A1ALOX15FNTAPGGT1B | |
| SCHEMBL21067036 | 0.79 | ALDH1A1 (0.58) | PTPN1ALDH1A1ALOX15FNTAPGGT1B | |
| SCHEMBL2861896 | 0.77 | LSS (0.46) | PTPN1LSS | |
| SCHEMBL2861895 | 0.77 | LSS (0.46) | PTPN1LSS | |
| SCHEMBL28520127 | 0.77 | PTPN1 (0.34) | PTPN1ALDH1A1ALOX15SQLELSS | |
| SCHEMBL2855422 | 0.76 | LSS (0.51) | ALDH1A1LSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7728180-B2 | Method for producing ethers | KURARAY CO., LTD. (JP) | 2010-06-01 | — | — | US | disclosed |
| US-20080262272-A1 | Method For Producing Ethers | KURARAY CO., LTD. (JP) | 2008-10-23 | — | — | US | disclosed |
| EP-1760061-A1 | METHOD FOR PRODUCING ETHERS | KURARAY CO., LTD. (JP) | 2007-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080262272-A1 | Method For Producing Ethers | TELO2, PDS5A, TERT | PTPN1 2589/4885ALDH1A1 3068/4885ALOX15 1527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.